Givaudan SA
GIVN: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|@^ | LOCK|Hk | LOCK|&N%Vn$ |
Givaudan Earnings: Better-Than-Expected Organic Growth With Signs of Volume Recovery
Wide-moat Givaudan reported 2023 organic sales growth of 4.1%, ahead of the 3.6% company-compiled consensus. Both reporting segments contributed to the overdelivery, with the fragrance and beauty segment recording the highest delta (7.6% actual compared with 6.8% consensus) as consumer fragrance volume growth picked up in the fourth quarter and the fine fragrance subsegment continued to deliver stellar performance. The strong Swiss franc weighed significantly on the top line, however, leading to reported sales growth of negative 2.8% for the year.
